Enhanced osteogenic differentiation of stem cells via microfluidics synthesized nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 7, 2015, Pages 1809-1819

  Hasani Sadrabadi, Mohammad Mahdi ^a,b,c   Pour Hajrezaei, Sana ^b   Hojjati Emami, Shahriar ^b   Bahlakeh, Ghasem ^b   Daneshmandi, Leila ^d   Dashtimoghadam, Erfan ^e   Seyedjafari, Ehsan ^f   Jacob, Karl I ^a   Tayebi, Lobat ^e,g  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

^c ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^d Temple University   (United States)

^e MARQUETTE UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^f UNIVERSITY OF TEHRAN   (Iran)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug delivery; Microfluidics platform; Osteogenic differentiation; Polymeric nanoparticles

Indexed keywords

BONE; CELL CULTURE; CONTROLLED DRUG DELIVERY; COST ENGINEERING; DRUG DELIVERY; MICROFLUIDICS; MOLECULAR DYNAMICS; NANOPARTICLES; POLYMERS; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY; TISSUE REGENERATION;

BONE TISSUE ENGINEERING; CELLULAR DIFFERENTIATION; CONVENTIONAL APPROACH; INTRACELLULAR DELIVERY; MESENCHYMAL STEM CELL; MOLECULAR DYNAMICS SIMULATIONS; OSTEOGENIC DIFFERENTIATION; POLYMERIC NANOPARTICLES;

STEM CELLS;

DEXAMETHASONE; NANOPARTICLE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE REGENERATION; BONE TISSUE; CELL DIFFERENTIATION; CELL FATE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENGINEERING; MESENCHYMAL STEM CELL; MICROFLUIDICS; MOLECULAR DYNAMICS; NONHUMAN; OSTEOGENIC DIFFERENTIATION; RAT; BONE; BONE DEVELOPMENT; CHEMISTRY; DRUG EFFECTS; FLOW CYTOMETRY; HUMAN; MESENCHYMAL STROMA CELL; TISSUE ENGINEERING;

BONE AND BONES; BONE REGENERATION; CELL DIFFERENTIATION; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; HUMANS; MESENCHYMAL STROMAL CELLS; MICROFLUIDICS; MOLECULAR DYNAMICS SIMULATION; NANOPARTICLES; OSTEOGENESIS; TISSUE ENGINEERING;

EID: 84942101322     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.04.005     Document Type: Article

References (34)

1. Huang Y., Zhou G., Zheng L., Liu H., Niu X., Fan Y. Micro-/Nano- sized hydroxyapatite directs differentiation of rat bone marrow derived mesenchymal stem cells towards an osteoblast lineage. Nanoscale 2012, 4:2484-2490.
2. Burg K.J.L., Porter S., Kellam J.F. Biomaterial developments for bone tissue engineering. Biomaterials 2000, 21:2347-2359.
3. Santos J.L.s., Oramas E., PÃago A.P., Granja P.L., TomÃs H. Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors. J Control Release 2009, 134:141-148.
4. Rickard D.J., Sullivan T.A., Shenker B.J., Leboy P.S., Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 1994, 161:218-228.
5. Oliveira J.M., Sousa R.A., Kotobuki N., Tadokoro M., Hirose M., Mano J.o.F., et al. The osteogenic differentiation of rat bone marrow stromal cells cultured with dexamethasone-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles. Biomaterials 2009, 30:804-813.
6. Nuttelman C.R., Tripodi M.C., Anseth K.S. Dexamethasone-functionalized gels induce osteogenic differentiation of encapsulated hMSCs. J Biomed Mater Res A 2006, 76A:183-195.
7. Koehler K.C., Alge D.L., Anseth K.S., Bowman C.N., Diels-Alder A. Modulated approach to control and sustain the release of dexamethasone and induce osteogenic differentiation of human mesenchymal stem cells. Biomaterials. 2013, 34:4150-4158.
8. Majedi F.S., Hasani-Sadrabadi M.M., VanDersarl J.J., Mokarram N., Hojjati-Emami S., Dashtimoghadam E., et al. On-chip fabrication of paclitaxel-loaded chitosan nanoparticles for cancer therapeutics. Adv Funct Mater 2013, 24:432-441.
9. Hasani-Sadrabadi M.M., Karimkhani V., Majedi F.S., Van Dersarl J.J., Dashtimoghadam E., Afshar-Taromi F., et al. Microfluidic-assisted self-assembly of complex dendritic polyethylene drug delivery nanocapsules. Adv Mater 2014, 26:3118-3123.
10. Hasani-Sadrabadi M.M., Majedi F.S., VanDersarl J.J., Dashtimoghadam S.E., Ghaffarian S.R., Bertsch A., et al. Morphological tuning of polymeric nanoparticles via microfluidic platform for fuel cell applications. J Am Chem Soc 2012, 134:18904-18907.
11. Majedi F.S., Hasani-Sadrabadi M.M., Emami S.H., Taghipoor M., Dashtimoghadam E., Bertsch A., et al. Microfluidic synthesis of chitosan-based nanoparticles for fuel cell applications. Chem Commun 2012, 48:7744-7746.
12. Bodnar M., Hartmann J.F., Borbely J. Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 2005, 6:2521-2527.
13. Majedi F.S., Hasani-Sadrabadi M.M., Hojjati Emami S., Shokrgozar M.A., VanDersarl J.J., Dashtimoghadam E., et al. Microfluidic assisted self-assembly of chitosan based nanoparticles as drug delivery agents. Lab Chip 2013, 13:204-207.
14. Kamaly N., Xiao Z., Valencia P.M., Radovic-Moreno A.F., Farokhzad O.C. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 2012, 41:2971-3010.
15. Wacker J.B., Lignos I., Parashar V.K., Gijs M.A.M. Controlled synthesis of fluorescent silica nanoparticles inside microfluidic droplets. Lab Chip 2012, 12:3111-3116.
16. deMello A.J. Control and detection of chemical reactions in microfluidic systems. Nature 2006, 442:394-402.
17. Mark D., Haeberle S., Roth G., von Stetten F., Zengerle R. Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications. Chem Soc Rev 2010, 39:1153-1182.
18. Mathews S., Bhonde R., Gupta P.K., Totey S. Extracellular matrix protein mediated regulation of the osteoblast differentiation of bone marrow derived human mesenchymal stem cells. Differentiation 2012, 84:185-192.
19. Dashtimoghadam E., Mirzadeh H., Taromi F.A., Nystrom B. Microfluidic self-assembly of polymeric nanoparticles with tunable compactness for controlled drug delivery. Polymer 2013, 54:4972-4979.
20. Hasani-Sadrabadi M.M., VanDersarl J.J., Dashtimoghadam E., Bahlakeh G., Majedi F.S., Mokarram N., et al. A microfluidic approach to synthesizing high-performance microfibers with tunable anhydrous proton conductivity. Lab Chip 2013, 13:4549-4553.
21. Karnik R., Gu F., Basto P., Cannizzaro C., Dean L., Kyei-Manu W., et al. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett 2008, 8:2906-2912.
22. Korb V., Tep K., Escriou V., Richard C., Scherman D., Cynober L., et al. Current data on ATP-containing liposomes and potential prospects to enhance cellular energy status for hepatic applications. Crit Rev Ther Drug Carrier Syst 2008, 25:305-345.
23. Verma D., Levchenko T., Bernstein E., Torchilin V. ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model. J Control Release 2005, 108:460-471.
24. Liang W., Levchenko T., Torchilin V. Encapsulation of ATP into liposomes by different methods: optimization of the procedure. J Microencapsul 2004, 21:251-261.
25. Malafaya P.c.B., Silva G.A., Reis R.L. Naturalâ€"origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev 2007, 59:207-233.
26. Baldwin S.P., Mark Saltzman W. Materials for protein delivery in tissue engineering. Adv Drug Deliv Rev 1998, 33:71-86.
27. Parez R.A., Won J.-E., Knowles J.C., Kim H.-W. Naturally and synthetic smart composite biomaterials for tissue regeneration. Adv Drug Deliv Rev. 2013, 65:471-496.
28. Patschan D., Loddenkemper K., Buttgereit F. Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 2001, 29:498-505.
29. Gerstenfeld L.C., Thiede M., Seibert K., Mielke C., Phippard D., Svagr B., et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003, 21:670-675.
30. McCulloch C.A.G., Tenenbaum H.C. Dexamethasone induces proliferation and terminal differentiation of osteogenic cells in tissue culture. Anat Rec 1986, 215:397-402.
31. Lu L., Wu L., Jia H., Li Y., Chen J., Xu D., et al. The epithelial sodium channel is involved in dexamethasone-induced osteoblast differentiation and mineralization. Cell Biol Toxicol. 2012, 28:279-289.
32. Martins A., Duarte A.R.C., Faria S., Marques A.P., Reis R.L., Neves N.M. Osteogenic induction of hBMSCs by electrospun scaffolds with dexamethasone release functionality. Biomaterials. 2010, 31:5875-5885.
33. Shin S.-J., Park J.-Y., Lee J.-Y., Park H., Park Y.-D., Lee K.-B., et al. "On the fly" continuous generation of alginate fibers using a microfluidic device. Langmuir 2007, 23:9104-9108.
34. Oshina H., Sotome S., Yoshii T., Torigoe I., Sugata Y., Maehara H., et al. Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Bone 2007, 41:575-583.